Reynolds American (RAI) - FREE Research Report

Brown & Williamson Holdings, Inc. who is 10% Owner at Reynolds American sold 122,491 shares at $51.47 on Nov. 5, 2013. Following this transaction, the 10% Owner owned 226.8 million shares meaning that the stake was reduced by 0.05% with the 122,491 share transaction.

The shares most recently traded at $51.72, up $0.25, or 0.48% since the insider transaction. Historical insider transactions for Reynolds American go as follows:

  • 4-Week # shares sold: 376,540
  • 12-Week # shares sold: 1.2 million
  • 24-Week # shares sold: 2.8 million

The average volume for Reynolds American has been 1.5 million shares per day over the past 30 days. Shares are up 24.06% year to date as of the close of trading on Tuesday.

Reynolds American Inc., through its subsidiaries, manufactures and sells cigarette and other tobacco products in the United States. The company operates through RJR Tobacco, American Snuff, and Santa Fe segments. The stock currently has a dividend yield of 4.94%. The company has a P/E ratio of 17.8. Currently there are 2 analysts that rate Reynolds American a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RAI - FREE

TheStreet Quant Ratings rates Reynolds American as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Reynolds American Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Develop Biotech 'Buy-Sell' Strategy

Develop Biotech 'Buy-Sell' Strategy

Two Small-Cap Biotechs To Consider

Two Small-Cap Biotechs To Consider

Next Year's Stock Returns: 5% or 15%?

Next Year's Stock Returns: 5% or 15%?

Updating a Small Speculative Play

Updating a Small Speculative Play

Three Large-Cap Growth Stocks

Three Large-Cap Growth Stocks